US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist
  • 0.746
  • -0.006-0.82%
Close Jul 5 16:00 ET
  • 0.750
  • +0.005+0.60%
Post 19:42 ET
52.89MMarket Cap-1035P/E (TTM)

Ovid Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ovid Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

148.00K

+124.24%
EPS(YoY)

-0.17

+10.53%
Analyst Rating

Buy

Jul 6, 2024

Ovid Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 57.250K--
--2024/Q2-- / 52.880K--
--2024/Q1148.000K / 52.120K--
--2023/Q4141.560K / 10.035M--
--2023/Q3108.970K / 43.750K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 57.250K--
--2024/Q2-- / 52.880K--
--2024/Q1148.000K / 52.120K--
--2023/Q4141.560K / 10.035M--
--2023/Q3108.970K / 43.750K--

Unlock Free Earnings Estimates

Ovid Therapeutics Earnings Reports

  • Ovid Therapeutics | 10-Q: Quarterly report

    May 14 20:14

  • Ovid Therapeutics | 10-K: Annual report

    Mar 8 21:30

  • Ovid Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 20:13

  • Ovid Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 4, 2023 21:23

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 6, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg